---
templateKey: publications-page
title: Publications
subtitle: >-
  TNBC, TGFβ isoforms, Breast cancer Stem Cells, MicroRNA-30, CPSF6,
  Cyclooxygenase-2 
headerImage: /img/dna-1811955_1280.jpg
---
# 2018

* Critical Role for Kinesin 1 Heavy Chain KIF5B in TNBC Aggressive Phenotype Independent of its Partner Protein Kinesin-1 Light Chain KLC1. EMBO J (Submitted).Moamer A, Binothman N, Hachim I, Lebrun JJ, Ali S.
* Prolactin Hormone Exerts Anti-Tumorigenic Effects in HER-2 Overexpressing Breast Cancer Cells through Regulation of Tumor Initiation and Stemness. Nature Scientific Reports (submitted).Hachim I, López-Ozuna VM, Hachim M, Lebrun JJ, Ali S. 
* Blocking microRNA-30 in triple negative breast Cancer can restore pro-apoptotic programs and block tumor development in vivo. Nature Communications (submitted).Fils-Aime N, Poulet S, Neel JC, Dai, M, Hachim, I, Ali S, Lebrun JJ. 
* Dasatinib targeting of breast cancer stem cells sensitize triple negative breast cancer cells to chemotherapy. Clin Cancer Res (submitted).Tian J, Al Raffa F, Dai M, Khandag B, Bakdounes K, Jean-Claude B, Ali S, Lebrun JJ. (2018).
* [Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.](https://www.ncbi.nlm.nih.gov/pubmed/29320969) Hachim MY, Hachim IY, Dai M, Ali S, Lebrun JJ. Tumour Biol. 2018 Jan;40(1):1010428317748254. doi: 10.1177/1010428317748254
* [KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer](https://www.ncbi.nlm.nih.gov/pubmed/?term=KiSS1+gene+as+a+novel+mediator+of+TGF%CE%B2-mediated+cell+invasion+in+triple+negative+breast+cancer.).
  Tian J, Al-Odaini AA, Wang Y, Korah J, Dai M, Xiao L, Ali S, Lebrun JJ.
  Cell Signal. 2018 Jan;42:1-10. doi: 10.1016/j.cellsig.2017.10.002. Epub 2017 Oct 6.

# 2017

* [Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration.](https://www.nature.com/articles/s41598-017-14549-9) Hachim IY, Villatoro M, Canaff L, Hachim MY, Boudreault J, Haiub H, Ali S, Lebrun JJ. Sci Rep. 2017 Nov 3;7(1):14976. doi: 10.1038/s41598-017-14549-9.
* [CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer.](https://www.ncbi.nlm.nih.gov/pubmed/28673861) Binothman N, Hachim IY, Lebrun JJ, Ali S. EBioMedicine. 2017 Jul;21:65-78. doi: 10.1016/j.ebiom.2017.06.023. Epub 2017 Jun 24.
* [Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer](https://www.nature.com/articles/srep40258). Tian J, Hachim MY, Hachim IY, Dai M, Lo C, Al Raffa F, Ali S, Lebrun JJ. doi:10.1038/srep40258 
* [Revealing determinant factors for early breast cancer recurrence by decision tree.](https://link.springer.com/article/10.1007/s10796-017-9764-0) Guo J, Fung BCM, Kuppen PJK, Tollenaar RAEM, Mesker WE, and Lebrun JJ. Information Systems Frontiers (ISF), 13 pages, in press. 

# 2016

* [CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer](<CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer.>).Dai M, Zhang C, Ali A, Hong X, Tian J, Lo C, Fils-Aimé N, Burgos SA, Ali S, Lebrun JJ.
  Sci Rep. 2016 Oct 19;6:35383. doi: 10.1038/srep35383.
* [Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy](<Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy>). López-Ozuna VM, Hachim IY, Hachim MY, Lebrun JJ, Ali S. Sci Rep. 2016 Aug 2;6:30934. doi: 10.1038/srep30934.
* [Cell-specific optoporation with near-infrared ultrafast laser and functionalized gold nanoparticles.](<Cell-specific optoporation with near-infrared ultrafast laser and functionalized gold nanoparticles.>) Bergeron E, Boutopoulos C, Martel R, Torres A, Rodriguez C, Niskanen J, Lebrun JJ, Winnik FM, Sapieha P, Meunier M. Nanoscale. 2015 Nov 14;7(42):17836-47. doi: 10.1039/c5nr05650k. Epub 2015 Oct 13.
* [Prolactin/Jak2 directs apical/basal polarization and luminal linage maturation of mammary epithelial cells through regulation of the Erk1/2 pathway.](<Prolactin/Jak2 directs apical/basal polarization and luminal linage maturation of mammary epithelial cells through regulation of the Erk1/2 pathway.>) Liu F, Pawliwec A, Feng Z, Yasruel Z, Lebrun JJ, Ali S. Stem Cell Res. 2015 Sep;15(2):376-83. doi: 10.1016/j.scr.2015.08.001. Epub 2015 Aug 11.
* [Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.](<Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.>) Hachim IY, Hachim MY, Lopez VM, Lebrun JJ, Ali S. Appl Immunohistochem Mol Morphol. 2016 Apr;24(4):238-45. doi: 10.1097/PAI.0000000000000178.
* [CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer](<CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer>). Dai M, Zhang C, Ali A, Hong X, Lebrun JJ. Scientific Reports volume 6, Article number: 35383 (2016)
* [The Retinoblastoma Tumor Suppressor Protein (pRb)/E2 Promoter Binding Factor 1 (E2F1) Pathway as a Novel Mediator of TGFβ-induced Autophagy](<The Retinoblastoma Tumor Suppressor Protein (pRb)/E2 Promoter Binding Factor 1 (E2F1) Pathway as a Novel Mediator of TGFβ-induced Autophagy>). Korah J, Canaff L, Lebrun JJ. J Biol Chem. 2016 Jan 29;291(5):2043-54. doi: 10.1074/jbc.M115.678557. Epub 2015 Nov 23.
* [A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.](<A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.>) Hachim IY, Shams A, Lebrun JJ, Ali S. Hum Pathol. 2016 Jul;53:142-52. doi: 10.1016/j.humpath.2016.02.010. Epub 2016 Mar 14.
* [A dual prognostic role for the TGFβ receptors in human breast cancer](<A dual prognostic role for the TGFβ receptors in human breast cancer>). Hachim IY, Hachim MY, Lopez-Ozuna VM, Ali S, Lebrun JJ.Hum Pathol. Jul 18. pii: S0046-8177(16)30143-5.  doi: 10.1016/j.humpath.2016.07.002

# 2015

* [The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.](<The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.>) Humbert L, Ghozlan M, Canaff L, Tian J, Lebrun JJ. BMC Cancer. 2015 Mar 29;15:200. doi: 10.1186/s12885-015-1177-1

# 2014

* [Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.](<Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.>) Guo J, Canaff L, Rajadurai CV, Fils-Aimé N, Tian J, Dai M, Korah J, Villatoro M, Park M, Ali S, Lebrun JJ. Breast Cancer Res. 2014 Dec 13;16(6):476. doi: 10.1186/s13058-014-0476-9.

# 2013

* [Development of buffers for fast semidry transfer of proteins](<Development of buffers for fast semidry transfer of proteins>). Garić D, Humbert L, Fils-Aimé N, Korah J, Zarfabian Y, Lebrun JJ, Ali S. Anal Biochem. 2013 Oct 15;441(2):182-4. doi: 10.1016/j.ab.2013.07.009. Epub 2013 Jul 16.
* [Visible and near infrared resonance plasmonic enhanced nanosecond laser optoporation of cancer cells.](<Visible and near infrared resonance plasmonic enhanced nanosecond laser optoporation of cancer cells.>) St-Louis Lalonde B, Boulais E, Lebrun JJ, Meunier M. Biomed Opt Express. 2013 Apr 1;4(4):490-9. doi: 10.1364/BOE.4.000490. Epub 2013 Mar 1.
* [Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells](<Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells>). Neel JC, Lebrun JJ. Cell Signal. 2013 Jul;25(7):1556-66. doi: 10.1016/j.cellsig.2013.03.013. Epub 2013 Mar 22
* [MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-β Mediates the migration and actin dynamics of breast cancer cells.](<MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-β Mediates the migration and actin dynamics of breast cancer cells.>) Fils-Aimé N, Dai M, Guo J, El-Mousawi M, Kahramangil B, Neel JC, Lebrun JJ. J Biol Chem. 2013 Apr 26;288(17):11807-23. doi: 10.1074/jbc.M112.430934. Epub 2013 Mar 11.
* [TGF-beta inhibits human cutaneous melanoma cell migration and invasion through regulation of the plasminogen activator system](<TGF-beta inhibits human cutaneous melanoma cell migration and invasion through regulation of the plasminogen activator system>). Humbert L, Lebrun JJ. Cell Signal. 2013 Feb;25(2):490-500. doi: 10.1016/j.cellsig.2012.10.011. Epub 2012 Oct 23.
